Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

1.34
Data as of Apr 17
 -0.05 / -3.60%
Today’s Change
1.27
Today|||52-Week Range
8.40
-26.78%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$75.1M

Company Description

AVEO Pharmaceuticals, Inc. does business as AVEO Oncology is a cancer therapeutics company, which is discovering, developing and commercializing targeted therapies to impact patients lives. The company's product candidate, Tivozanib, which is designed to provide an optimal blockade of the vascular endothelial growth factor, or VEGF, pathway by inhibiting all three VEGF receptors. It also has a pipeline of monoclonal antibodies, including ficlatuzumab, a product candidate that is currently in phase 2 clinical developments, derived from its Human Response Platform, a novel method of building preclinical models of human cancer. The company was founded by Ronald A. DePinho, Lynda Chin and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.

Contact Information

AVEO Pharmaceuticals, Inc.
75 Sidney Street
Cambridge Massachusetts 02139
P:(617) 299-5000
Investor Relations:
(617) 299-5810

Employees

Shareholders

Other institutional41.59%
Mutual fund holders17.06%
Individual stakeholders13.30%

Top Executives

Tuan Ha-NgocPresident, Chief Executive Officer, CFO & Director
Jeno GyurisChief Scientific Officer & Senior Vice President
William J. SlichenmyerChief Medical Officer
Anna BerkenblitVice President & Head-Clinical Research
Albert DaurayVice President-Information Technology

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.